Man Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Man Group’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,429	Closed	-$68K	–	2017
2019 Q4	$68K	Buy	+20,429	New	+$65K	﹤0.01%	1807
2019 Q3	–	Sell	-100,151	Closed	-$238K	–	2010
2019 Q2	$238K	Sell	100,151 -211,020	-68%	-$630K	﹤0.01%	1783
2019 Q1	$1.17M	Sell	311,171 -114,107	-27%	-$427K	﹤0.01%	1536
2018 Q4	$1.53M	Buy	+425,278	New	+$1.85M	0.01%	1321

Man Group's FOMX Position: Q1 2020 in Review

Man Group sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 20,429 shares — an estimated $68K sold.

Man Group first reported a position in FOMX in Q4 2018 and held it in 4 quarters. The position peaked at $1.53M in Q4 2018. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Man Group reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Man Group sold 20,429 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $68K.
Man Group first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2018 and held it in 4 quarters.
Man Group's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1.53M in Q4 2018.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Man Group's 13F filing for Q1 2020, filed 15 May 2020.